Dear Editor: Winkelmann et al[1] presented evidence on the usefulness of multispectral digital skin lesion analysis (MelaFind®; MELA Sciences, Inc.) as an aid in evaluating pigmented lesions (PLs) that have one or more clinical or historical characteristics of melanoma in community-based practice.[2–4] Among 137 lesions selected for biopsy, all 21 lesions with a negative test … Continue reading How Confident Should We Be?
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
